Characterization of a selective CaMKII peptide inhibitor

European Journal of Medicinal Chemistry

Volumn 62, Issue , 2013, Pages 425-434

  Gomez Monterrey, Isabel ^a   Sala, Marina ^b   Rusciano, Maria Rosaria ^a   Monaco, Sara ^a   Maione, Angela Serena ^a   Iaccarino, Guido ^b   Tortorella, Paolo ^c   D'Ursi, Anna Maria ^b   Scrima, Mario ^b   Carotenuto, Alfonso ^a   De Rosa, Giuseppe ^a   Bertamino, Alessia ^b   Vernieri, Ermelinda ^b   Grieco, Paolo ^a   Novellino, Ettore ^a   Illario, Maddalena ^a   Campiglia, Pietro ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Ca2+ calmodulin dependent protein kinase; CaM KNtide analogs; CaMKinase II inhibitor; Cell growth inhibition; Protein kinase

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CELL PENETRATING PEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN INHIBITOR;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOTOXICITY; FIBROBLAST; GENE FUSION; HUMAN; HUMAN CELL; IC 50; NUCLEAR MAGNETIC RESONANCE; PEPTIDE SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HUMANS; MCF-7 CELLS; PEPTIDE FRAGMENTS; PROTEIN KINASE INHIBITORS; RATS; RATS, INBRED WKY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84873433183     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.12.053     Document Type: Article

References (76)

1. 2+/CaM-dependent kinase: from activation to function Annu. Rev. Pharmacol. Toxicol. 41 2001 471 505
2. 2+/calmodulin dependent protein kinase II J. Biol. Chem. 76 2002 3719 3722
3. T. Tobimatsu, and H. Fujisawa Tissue specific expression of four types of rat calmodulin-dependent protein kinase II transcripts J. Biol. Chem. 264 1989 17907 17912
4. A.P. Braun, and H. Schulman The multifunctional calcium/calmodulin- dependent protein kinase: from form to function Annu. Rev. Physiol. 57 1995 417 445
5. T. Meyer, P.I. Hanson, L. Stryer, and H. Schulman Calmodulin trapping by calcium-calmodulin-dependent protein kinase Science 256 1992 1199 1202
6. 2+/calmodulin-dependent protein kinase II Biochem. J. 364 2002 593 611 (and references therein)
7. G.Y. Wu, and H.T. Cline Stabilization of dendritic arbor structure in vivo by CaMKII Science 279 1998 222 226
8. R.J. Colbran, and A.M. Brown Calcium/calmodulin-dependent protein kinase II and synaptic plasticity Curr. Opin. Neurobiol. 14 2004 318 322
9. K.P. Giese, N.B. Fedorov, R.K. Filipkowski, and A.J. Silva Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning Science 279 1998 870 873
10. J. Lisman, H. Schulman, and H. Cline The molecular basis of CaMKII function in synaptic and behavioural memory Nat. Rev. Neurosci. 3 2002 175 190
11. Y.S. Lee, and A.J. Silva The molecular and cellular biology of enhanced cognition Nat. Rev. Neurosci. 10 2009 126 140
12. I. Buard, S.J. Coultrap, R.K. Freund, Y.-S. Lee, M.L. Dell'acqua, A.J. Silva, and K.U. Bayer CaMKII "autonomy" is required for initiating but not for maintaining neuronal long-term information storage J. Neurosci. 30 2010 8214 8220
13. M. Sanhueza, G. Fernandez-Villalobos, I.S. Stein, G. Kasumova, P. Zhang, K.U. Bayer, N. Otmakhov, J.W. Hell, and J. Lisman Role of the CaMKII/NMDA receptor complex in the maintenance of synaptic strength J. Neurosci. 31 2011 9170 9178
14. C.R. Kahl, and A.R. Means Regulation of cell cycle progression by calcium/calmodulin-dependent pathways Endocr. Rev. 24 2003 719 736
15. K. Yuan, L.W.K. Chung, G.P. Siegal, and M. Zayzafoon Alpha-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression Lab. Invest. 87 2007 938 950
16. 2+/calmodulin dependent kinase II (CaMKII) is activated in papillary thyroid carcinoma and mediates cell proliferation stimulated by RET/PTC Endocr. Relat. Cancer 17 2010 113 123
17. M.H. Olofsson, A.M. Havelka, S. Brnjic, M.C. Shoshan, and S. Linder Charting calcium-regulated apoptosis pathways using chemical biology: role of calmodulin kinase II BMC Chem. Biol. 2008 10.1186/1472-6769-8-2
18. T.L. Herrmann, C.T. Morita, K. Lee, and D.J. Kusner Calmodulin kinase II regulates the maturation and antigen presentation of human dendritic cells J. Leukoc. Biol. 78 2005 1397 1407
19. J.D. Bui, S. Calbo, K. Hayden-Martinez, L.P. Kane, P. Gardner, and S.M. Hedrick A role for CaMKII in T cell memory Cell 100 2000 457 467
20. J. Erickson, R. Patel, G. Hart, and D. Bers Specific intracellular glycosylation directly modulates CamKII activity during hyperglycemia Circulation 122 2010 A20245
21. M. Illario, S. Monaco, A.L. Cavallo, I. Esposito, P. Formisano, L. D'Andrea, E. Cipolletta, B. Trimarco, G. Fenzi, G. Rossi, and M. Vitale Calcium-calmodulin-dependent kinase II (CaMKII) mediates insulin-stimulated proliferation and glucose uptake Cell. Signal. 21 2009 786 792
22. C.E. Grueter, S.A. Abiria, Y. Wu, M.E. Anderson, and R.J. Colbran Differential regulated interactions of calcium/calmodulin-dependent protein kinase II with isoforms of voltage-gated calcium channel beta subunits Biochemistry 47 2008 1760 1767
23. + channels J. Clin. Invest. 116 2006 3127 3138
24. J.R. Erickson, M.A. Joiner, X. Guan, W. Kutschke, J. Yang, C.V. Oddis, K. Ryan, R.K. Bartlett, J.S. Lowe, S.E. O'Donnell, N. Aykin-Burns, M.C. Zimmerman, K. Zimmerman, A.L. Ham, R.M. Weiss, D.R. Spitz, M.A. Shea, R.J. Colbran, P.J. Mohler, and M.E. Anderson A dynamic pathway for calcium-independent activation of CamKII by methionine oxidation Cell 133 2008 462 474
25. 2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart Cardiovasc. Res. 73 2007 631 640
26. 2+/calmodulin-dependent protein kinase II as demonstrated tandem mass spectrometry Neurosci. Lett. 353 2003 185 188
27. 2+/Calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental Parkinsonism J. Neurosci. 24 2004 5283 5291
28. S.J. Coultrap, R.S. Vest, N.M. Ashpole, A. Hudmon, and K.U. Bayer CaMKII in cerebral ischemia Acta Pharmacol. Sin. 32 2011 861 872
29. R.M. Tombes, and G.W. Krystal Identification of novel human tumor cell-specific CaMK-II variants Biochim. Biophys. Acta 1355 1997 281 292
30. B.F. Yang, C. Xiao, W.H. Roa, P.H. Krammer, and C. Hao Calcium/calmodulin dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells J. Biol. Chem. 278 2003 7043 7050
31. O.W. Rokhlin, A.F. Taghiyev, K.U. Bayer, D. Bumcrot, V.E. Koteliansk, R.A. Glover, and M.B. Cohen Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival Cancer Biol. Ther. 6 2007 732 742
32. 2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure Cardiovasc. Res. 63 2004 476 486
33. R. Zhang, M.S.C. Khoo, Y. Wu, Y. Yang, C.E. Grueter, G. Ni, E.E. Price Jr., W. Thiel, S. Guatimosin, L.S. Song, E.C. Madu, A.N. Shah, T.A. Vishnivetskaya, J.B. Atkinson, V.V. Gurevich, G. Salama, W.J. Lederer, R.J. Colbran, and M.E. Anderson Calmodulin kinase II inhibition protects against structural heart disease Nat. Med. 11 2005 409 417
34. K. Højlund, J.B. Birk, D.K. Klein, K. Levin, A.R. Rose, B.F. Hansen, J.N. Nielsen, H. Beck-Nielsen, and J.F.P. Wojtaszewski Dysregulation of glycogen synthase COOH- and NH2-terminal phosphorylation by insulin in obesity and type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab. 94 2009 4547 4556
35. R. Malinow, H. Schulman, and R.W. Tsien Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP Science 245 1989 862 866
36. 2+/Calmodulin-dependent protein kinase, decreases early after depolarizations in rabbit heart J. Pharmacol. Exp. Ther. 287 1998 996 1006
37. 2+/Calmodulin- dependent protein kinase II (CaMKII) inhibitor J. Biol. Chem. 285 2010 20675 20682
38. 2+/calmodulin-dependent protein kinase II J. Biol. Chem. 265 1990 4315 4320
39. 2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells Biochem. Biophys. Res. Commun. 181 1991 968 975
40. A. Ishida, I. Kameshita, S. Okuno, T. Kitani, and H. Fujisawa A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II Biochem. Biophys. Res. Commun. 212 1995 806 812
41. A.P. Braun, and H. Schulman A non-selective cation current activated via the multi-functional Ca(2+)-calmodulin-dependent protein kinase in human epithelial cells J. Physiol. 488 1995 37 55
42. O. Hvalby, H.G. Hemmings, O. Paulsen, A.J. Czernik, A.C. Nairn, J.M. Godfraind, V. Jensen, M. Raastad, J.F. Storm, P. Andersen, and P. Greengard Specificity of protein kinase inhibitor peptides and induction of long-term potentiation Proc. Natl. Acad. Sci. U. S. A. 91 1994 4761 4765
43. M.K. Smith, R.J. Colbran, and T.R. Soderling Specificities of autoinhibitory domain peptides for four protein kinases: implications for intact cell studies of protein kinase functions J. Biol. Chem. 265 1990 1837 1840
44. R.S. Vest, K.D. Davies, H. O'Leary, J.D. Port, and K.U. Bayer Dual mechanism of a natural CaMKII inhibitor Mol. Biol. Cell 18 2007 5024 5033
45. 2+/calmodulin-dependent protein kinase IV. Role in transcriptional regulation J. Biol. Chem. 269 1994 15520 15527
46. 2+ channels Mol. Pharmacol. 42 1992 489 498
47. + channels in vascular myocytes J. Pharmacol. Exp. Ther. 290 1999 1165 1174
48. B.H. Chang, S. Mukherji, and T. Soderling Characterization of a calmodulin kinase II inhibitor protein in brain Proc. Natl. Acad. Sci. U. S. A. 95 1998 10890 10895
49. B.H. Chang, S. Mukherji, and T. Soderling Calcium/calmodulin-dependent protein kinase II inhibitor protein: localization of isoforms in rat brain Neuroscience 102 2001 767 777
50. S.J. Coultrap, and K.U. Bayer Improving a natural CaMKII inhibitor by random and rational design PLoS One 6 2011 e25245
51. E. Cipolletta, S. Monaco, A.S. Maione, L. Vitiello, P. Campiglia, L. Pastore, C. Franchini, E. Novellino, V. Limongelli, K.U. Bayer, A.R. Means, G. Rossi, B. Trimarco, G. Iaccarino, and M. Illario Calmodulin-dependent kinase II mediates vascular smooth muscle cell proliferation and is potentiated by extracellular signal regulated kinase Endocrinology 151 2010 2747 2759
52. E. Atherton, and R.C. Sheppard Solid-phase Peptide Synthesis: A Practical Approach 1989 IRL Oxford
53. 2+/calmodulin-dependent protein kinase and mutational analysis of its auto regulation Neuron 3 1989 59 70
54. D. Chin, K.E. Winkler, and A.R. Means Characterization of substrate phosphorylation and use of calmodulin mutants to address implications from the enzyme crystal structure of calmodulin-dependent protein kinase I J. Biol. Chem. 272 1997 31235 31240
55. 2+/calmodulin J. Biol. Chem. 285 2010 17930 17937
56. L.H. Chao, P. Pellicen, S. Deindl, L.A. Barclay, H. Schulman, and J. Kuriyan Intersubunit capture of regulatory segments is a component of cooperative CaMKII activation Nat. Struct. Mol. Biol. 17 2010 264 272
57. Y.M. Lu, N. Shioda, F. Han, A. Kamata, Y. Shirasaki, Z.H. Qin, and K. Fukunaga DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities Cardiovasc. Ther. 27 2009 17 27
58. C. Wang, N. Li, X. Liu, Y. Zheng, and X. Cao A novel endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest via p27 stabilization J. Biol. Chem. 283 2008 11565 11574
59. F. Denizot, and R. Langa Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability J. Immunol. Methods 89 1986 271 277
60. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
61. M. Illario, A.L. Cavallo, K.U. Bayer, T. Di Matola, G. Fenzi, G. Rossi, and M. Vitale Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation J. Biol. Chem. 278 2003 45101 45108
62. M. Illario, A.L. Cavallo, S. Monaco, E. Di Vito, F. Mueller, L.A. Marzano, G. Troncone, G. Fenzi, G. Rossi, and M. Vitale Fibronectin-induced proliferation in thyroid cells is mediated by alphavbeta3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals J. Clin. Endocrinol. Metab. 90 2005 2865 2873
63. R. Rajan, S.K. Awasthi, S. Bhattacharjya, and P. Balaram Teflon-coated peptides: hexafluoroacetone trihydrate as a structure stabilizer for peptides Biopolymers 42 1997 125 128
64. 1H NMR Eur. J. Biochem. 192 1990 433 439
65. A.M. D'Ursi, S. Albrizio, G. Greco, S. Mazzeo, M.R. Mazzoni, E. Novellino, and P. Rovero Conformational analysis of the Gαs protein C-terminal region J. Pept. Sci. 8 2002 476 488
66. L. Whitmore, and B. Wallace DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data Nucleic Acids Res. 32 2004 W668
67. U. Piantini, O. Sorensen, and R. Ernst Multiple quantum filters for elucidating NMR coupling networks J. Am. Chem. Soc. 104 1982 6800 6801
68. A. Bax, and D. Davis MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy J. Magn. Reson. 65 1985 355 360
69. J. Jeener, B. Meier, P. Bachmann, and R. Ernst Investigation of exchange processes by two-dimensional NMR spectroscopy J. Chem. Phys. 71 1979 4546 4553
70. T. Goddard, and D. Kneller SPARKY 3 2004 University of California San Francisco
71. K. Wüthrich NMR of Proteins and Nucleic Acids 1986 Wiley-Interscience
72. P. Guntert, C. Mumenthaler, and K. Wuthrich Torsion angle dynamics for NMR structure calculation with the new program DYANA J. Mol. Biol. 273 1997 283 298
73. D. Case, D. Pearlman, J. Caldwell, T. Cheatham III, W. Ross, C. Simmerling, T. Darden, K. Merz, R. Stanton, and A. Cheng AMBER 5 1997 University of California San Francisco
74. D. Pearlman, D. Case, J. Caldwell, W. Ross, and T. Cheatham AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules Comput. Phys. Commun. 91 1995 1 41
75. R.A. Laskowski, V.V. Chistyakov, and J.M. Thornton PDBsum more: new summaries and analyses of the known 3D structures of proteins and nucleic acids Nucleic Acids Res. 33 2005 D266 D268
76. 2+/calmodulin and autophosphorylation of threonine 286 Biochemistry 41 2002 14001 14009